Acumen Pharmaceuticals In... (ABOS)

1.09

-0.01 (-0.91%)

At close: Apr 25, 2025, 3:59 PM

1.06

-2.66%

After-hours: Apr 25, 2025, 07:30 PM EDT

Acumen Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-102.33M	-52.37M	-42.86M	-100.61M	-7.33M	-7.91M
Depreciation & Amortization	178K	184K	169K	4K	n/a	n/a
Stock-Based Compensation	9.63M	6.14M	3.06M	922K	154K	174K
Other Working Capital	7.38M	4.13M	3.43M	-259K	-1K	658K
Other Non-Cash Items	-5.35M	-888K	487K	81.27M	-586K	147K
Deferred Income Tax	n/a	n/a	n/a	155K	n/a	n/a
Change in Working Capital	11.65M	3.87M	3.99M	298K	307K	768K
Operating Cash Flow	-86.22M	-43.06M	-35.15M	-17.96M	-7.45M	-6.82M
Capital Expenditures	-16K	-21K	-161K	-40K	n/a	n/a
Cash Acquisitions	n/a	n/a	-39.35K	n/a	n/a	n/a
Purchase of Investments	-170.73M	-250.63M	-41.51M	-104.08M	n/a	n/a
Sales Maturities Of Investments	218.77M	78.98M	80.86M	n/a	n/a	n/a
Other Investing Acitivies	n/a	3K	39.35K	-104.08K	n/a	n/a
Investing Cash Flow	48.03M	-171.67M	39.19M	-104.12M	n/a	n/a
Debt Repayment	-739K	30M	n/a	n/a	n/a	n/a
Common Stock Repurchased	-41K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-230K	-151K	115K	1.88M	n/a	7K
Financial Cash Flow	6.93M	151.75M	3.91M	200.47M	44.67M	6.24M
Net Cash Flow	-31.26M	-62.98M	7.94M	78.39M	37.23M	-579K
Free Cash Flow	-86.23M	-43.09M	-35.31M	-18M	-7.45M	-6.82M